ABM Respiratory Care is revolutionizing airway clearance and lung ventilation with our innovative approach to traditional therapies. Backed by strategic investors who believe in both our technology’s market-changing potential and our team’s ability to exceed expectations, we offer a unique combination of marketing, regulatory, quality, and engineering expertise. Join us as an investor and champion for global advancement in lung health.
ABM Respiratory Care aims to be the world’s fastest-growing and most innovative respiratory care company, delivering impactful solutions in airway clearance, lung ventilation, and telehealth.
We live by these values every day—in our innovation, our relationships, and the impact we strive to make.
ABM Respiratory Care is revolutionizing airway clearance and lung ventilation with our innovative approach to traditional therapies. Backed by strategic investors who believe in both our technology’s market-changing potential and our team’s ability to exceed expectations, we offer a unique combination of marketing, regulatory, quality, and engineering expertise. Join us as an investor and champion for global advancement in lung health.
Advanced Biomechanics
Private Limited
No. 1985, 9th Main Road, 26th Cross Road, Bangalore 560070,
Karnataka, India
+91 63604 09266
Advanced Bio
Machines PTE LTD
Registered Address: 36 Robinson Road, #20-01 City House
Singapore 068877
Office Address: 72 Bendemeer Road
#03-13 Luzerne
Singapore 339941
+65 6428 6218
ABMRC, LLC
860 Blue Gentian Road
Suite 200
Eagan, MN, 55121-1567
+1 877-226-7201
Greg Miller
CEO
Greg Miller was appointed CEO of ABM Respiratory Care in 2024, bringing decades of financial and operational leadership experience across global healthcare and industrial sectors. Prior to becoming CEO, Greg served as ABM’s Interim CEO since 2023 and a Board member since 2021.
Greg is a seasoned executive with deep experience leading global companies through growth, transformation and strategic transactions, including roles in both publicly traded and privately held companies with revenues up to $18 billion. Before joining ABM, Greg served as Group CFO at Advanced MedTech Holdings, the largest medical device company in Southeast Asia focused on urology devices and services. He was EVP and CIO at Genuine Parts Company (GPC), an $18 billion global distribution company, where he oversaw global business and IT operations, including digital commerce strategy, and CFO at NAPA Automotive Parts, GPC’s largest business unit.
Prior to GPC, Greg was the CFO at Hill-Rom Holdings, a medical device company, and Hillenbrand Industries, where he helped lead significant organic and acquisition growth and the successful separation of the holding company into two publicly traded entities. He also held multiple leadership positions at Newell Rubbermaid, including Group Vice President. Greg began his career in public accounting, spending eight years—primarily with Deloitte & Touche—advising emerging businesses and supporting M&A and IPO activities.
Greg attended the University of Chicago Booth School of Business to complete the Chicago Management Institute Program. He is a CPA with a bachelor’s degree in Accounting from University of Northern Iowa and an Associates of Arts degree in Information Systems from Waldorf College.
Vinay Joshi
CTO / Founder
Vinay is an entrepreneur with two decades of experience in the medical device industry. In addition to managing early stage start-up companies, Vinay held senior roles with GE Healthcare and Hill-Rom, where his responsibilities were focused on respiratory health products in the disciplines of product development and marketing. At GE Healthcare, he worked on diagnostic imaging and life support systems like ICU ventilation. At Hill-Rom, he worked on their airway clearance product portfolio.
Vinay has a degree in Engineering from IIT Delhi and MBA from IIM Bangalore.
Amodh Gr
Executive Director of R&D
Amodh has over nine years of experience leading medical device development. Prior to joining ABM, he led a development team at Larsen & Toubro Limited (L&T). He specializes in system engineering, mechanical and pneumatics design, as well as Matlab simulations.
Amodh has a degree in Mechanical Engineering from Visvesvaraya Technology University.
Leah Noaeill
VP of Marketing and Clinical Affairs
Leah has over twenty years experience in medical device marketing. Most recently, she was the Senior Marketing Director at NeuroOne Medical Technologies, a neuro tech startup, where she led marketing and assisted in developing a partnership with Zimmer Biomet. Prior to NeuroOne, Leah was a Senior Marketing Manager at Smiths Medical leading the Infusion Software marketing and application support teams. Leah also worked at Hill-Rom, managing their Respiratory Care device portfolio. Prior to Hillrom, Leah worked at Medtronic where she led marketing efforts for their Connected Care portfolio and implantable cardiac devices.
Leah has an MBA from University of Phoenix and a Bachelors of Business Administration from University of Minnesota – Duluth.
Sean Mellor
VP of US Sales and Customer Success
Peter Soderberg
Chairman of the Board
With over 50 years of service in the healthcare industry, Mr. Soderberg currently is Managing Partner for Worthy Venture Resources LLC. He also serves on the board and the executive committee of the Medical Technology Enterprise Consortium (MTEC), a 501(c)(3) accelerating biomedical technology research and development in collaboration with the U.S. Army Medical Research and Development Command (USAMRDC).
Mr. Soderberg recently concluded his service as Chairman of the Board of Directors for Tactile Medical (NASDAQ: TCMD), as well as 18 years of service on the board of directors of Integer Holdings Corp. (NYSE: ITGR, formerly Greatbatch, Inc.), a medical technology company. He previously served on the boards of Constellation Brands, Inc. (NYSE: STZ) and the Advanced Medical Technology Association.
Before his semi-retirement in 2010, Mr. Soderberg served as President and Chief Executive Officer of Hillenbrand Industries and Hill-Rom, and, before that, of Welch Allyn. He has also held executive positions at Johnson & Johnson in a variety of operations, marketing, and management roles, including President of Johnson & Johnson Health Management.
Mr. Soderberg received his degree in Engineering and Applied Sciences (Magna Cum Laude and Honors with Exceptional Distinction in Engineering) from Yale University.
Abel Ang
Board Director
Ang is the chairperson of Advanced MedTech Investments. Between 2014 and 2024, he led Advanced MedTech – Temasek Holding’s US$335M global platform in urology devices and services. As Founding President and Group CEO, he transformed the carved-out medical device platform from a loss-making unit to a top-3 performer(IRR-returns) within Temasek’s portfolio. He drove significant revenue growth by transforming the group’s product portfolio, achieving a 4- fold increase during his tenure, while simultaneously increasing EBITDA by 33 times without any additional capital from shareholders.
Ang boasts a proven track record of medtech innovation, having brought 100 distinct devices to market globally. He specializes in accelerating R&D productivity and scaling commercial organizations to extract maximum value from new product innovation, especially in the US. Advanced MedTech’s US revenue grew 10-fold during his tenure to US$200M with an annual growth-rate of 22.3% in 2024.
He served as Senior Advisor to the CEO of Greatbatch Inc. (NYSE: ITGR), supporting innovation across cardiac, neurology, vascular, and orthopedic markets. Prior to this, Ang led Hill-Rom Inc., a $3B medical device company (acquired by BAX), as President, Asia/Pacific. As Hill-Rom’s Chief Technology Officer, he oversaw global R&D operations spanning the U.S., Mexico, France, and Singapore. He also held key leadership roles including Vice-President and General Manager of the $420M Global Therapy Business Unit and Vice-President for International M&A. He formerly headed the global Medical Technology and Biotechnology industry groups in the Singapore Economic Development Board (EDB).
Ang sits on the Board of Economic Development Innovations Singapore, a privately-held investment holding company headquartered in Singapore with investments in deeptech and listed assets. He sits on the Boards of Advanced MedTech Holdings, SonoMotion Inc., ABM Respiratory Inc., and Vivance(formerly AWAK Technologies), where he chairs the Board. He was formerly on the Board and Nominating Committee of Aslan Pharmaceuticals (NYSE: ASLN).
On the education front, Ang is an adjunct full-professor at the Nanyang Business School in Singapore and Waseda University in Japan, where he teaches in their respective MBA programs.
Ang has a Master of Science in Computational Biology from Rutgers University in New Jersey, which he pursued while on an EDB scholarship. He attended Harvard Business School’s Advanced Management Program in 2012.
He was awarded the Public Service Medal (PBM) in 2021 for his contributions to the medical device industry in Singapore. He was again awarded the Public Service Medal (COVID-19) in 2022 for his innovative achievements during COVID.
Ang is married and has 2 grown boys. He writes and wing-foils in his free time.
Jonathan Black
Board Director
Jonathan Black has more than two decades of leadership and experience within the healthcare industry across the continuum of care and in a variety of disease states and conditions. Jonathan has served numerous roles including as an entrepreneur, operator, investor, and active board advisor. Throughout his healthcare career, Jonathan has relentlessly focused on leading organizations that deliver high-quality, patient-centered care, products, and services.
Presently, Jonathan is co-founder of Bluwave Capital, a boutique investment firm exclusively focused on partnering with companies solving today’s critical healthcare challenges. In addition, Jonathan serves as CEO of Wellsense, a healthcare technology company that identifies and helps prevent pressure injuries.
Previously in his career, Jonathan held CEO roles at DuraMedic, a hospital-centered durable medical equipment provider, Liberty Medical LLC, a home delivery medical supply service, and Omnis Health, a leading diabetes testing supply manufacturing company. He also served as Chief Development Officer of Press Ganey, the industry’s leading patient experience firm.
Jonathan earned a master’s degree from Babson College in business and a bachelor’s degree from Tufts University. He is a board member of The Carroll School, and is actively involved in numerous other healthcare, community, and non-profit organizations.
Doug Harper
Board Director
Tom Hill
Board Director
